It will carry data on all healthcare and biotechnology companies and organisations in the area and will be a valuable tool in attracting investment, CELS business development director Dr Ian Robson said.
"We also envisage using this tool to link bio-technology and healthcare companies interested in developing new products or working with others in related industries, with the aim of increasing collaboration and improving time to market of products," he said.
Rocket Science is to update and build on the centre's existing company database, including information on owners, key decision makers and areas of expertise. It will also provide data analysis support to identify areas of commercial potential.
Its projects director Graham Kay called the CELS brief challenging. "Our strong understanding of commercial business data and ability to create complex, yet user-friendly flexible databases will be the key to our work," he said.
The CELS, the main remit of which is to drive growth of biotechnology and healthcare in the region, is funded by development agency One North East.
If you have an opinion on this or any other issue raised on Brand Republic, join the debate in the Forum.